R

Rainbow Children's Medicare Ltd
NSE:RAINBOW

Watchlist Manager
Rainbow Children's Medicare Ltd
NSE:RAINBOW
Watchlist
Price: 1 145 INR 1.31% Market Closed
Market Cap: ₹116.3B

Rainbow Children's Medicare Ltd
Investor Relations

Rainbow Children's Medicare Ltd. embarked on its journey with a clear mission: to cater to the specialized healthcare needs of children. Nestled in the bustling corridors of India’s urban landscape, it emerged as a beacon of pediatric care, blending medical expertise with compassionate service. The company focuses on providing multi-specialty healthcare strictly for children, believing that specialized attention is key to superior medical outcomes. Over the years, Rainbow Children’s has cultivated a robust network of hospitals and clinics across multiple cities, each facility echoing the company’s commitment to innovative, child-focused treatment methodologies.

Strategically, Rainbow Children’s Medicare Ltd. thrives by offering a broad spectrum of pediatric services under one roof, which ensures a steady flow of clientele seeking diverse medical needs. This includes everything from routine check-ups and immunizations to complex procedures and intensive care. By establishing itself as a trust-worthy center for both routine and critical pediatric care, the company successfully draws a consistent and growing demand for its services. Financially, Rainbow Children's strengthens its revenue streams by strategically positioning hospitals in growing urban areas, tapping into insurance partnerships, and continually enhancing its offerings with advanced medical technologies and specialized care units. This strategic approach not only boosts operational efficiency but also ensures long-term sustainable growth as an essential player in the healthcare sector.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Jan 29, 2026
AI Summary
Q3 2026

Revenue Growth: Rainbow Hospitals reported Q3 FY26 revenue of INR 445.4 crores, up 12% year-on-year.

Profitability: EBITDA reached INR 147 crores, up 9% YoY, and profit after tax was INR 73.9 crores, increasing 7% YoY.

Occupancy: Occupancy for the quarter was 47.2%, with management targeting an increase to 55–60% going forward.

Expansion: Major recent capacity additions are largely complete, including new hospitals in Rajahmundry and Bangalore, shifting focus to ramping up occupancy.

Seasonal Impact: Lower outpatient and inpatient volumes were attributed to seasonality, particularly affecting mature hospitals.

Guidance Maintained: Management reaffirmed a medium-term goal of 18% revenue CAGR, despite current headwinds.

Margins Steady: EBITDA margin for Q3 was around 33%, with company-level margins expected to hold despite increased competition.

Digital & Operational Focus: The company is investing in sales, marketing, and digital initiatives to drive future growth.

Key Financials
Revenue
INR 445.4 crores
EBITDA
INR 147 crores
Profit After Tax
INR 73.9 crores
Occupancy
47.2%
EBITDA Margin
33%
Cash Position
INR 579 crores
Inpatient Discharges Growth
9%
Outpatient Volume Growth
18%
Deliveries Growth
16%
Average Length of Stay
2.73 days
IVF Business Revenue
INR 17–18 crores
Butterfly Essentials Revenue
INR 4 crores per quarter
Other Earnings Calls

Management

Dr. Ramesh Kancharla M. D. Peds
Founder, Chairman, Managing Director and Chief of Gastro Enterology & Hepatology Unit
No Bio Available
Mr. Vikas Maheshwari
Group Chief Financial Officer (KMP)
No Bio Available
Mr. Ashish Kapil
Nodal Officer, Company Secretary & Compliance Officer
No Bio Available
Dr. Dinesh Kumar Chirla (Ped), DM, M.D., MRCPCH (UK)
Whole-Time Director
No Bio Available
Mr. Mahesh Madduri
Head of Strategy
No Bio Available

Contacts

Address
TELANGANA
Hyderabad
Road No - 2, Banjara Hills, Near L V Prasad Eye Hospital,, Next to Hotel Park Hyatt,
Contacts